PROCTER & GAMBLE HEALTH Financial Statement Analysis
|
||
|
The Revenues of PROCTER & GAMBLE HEALTH have increased by 10.34% YoY .
The Earnings Per Share (EPS) of PROCTER & GAMBLE HEALTH has increased by 19.18 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
PROCTER & GAMBLE HEALTH Last 5 Annual Financial Results
[BOM: 500126|NSE : PGHL]
| Standalone | Jun2023 | Jun2022 | Jun2021 | Jun2020 | Dec2018 |
|---|---|---|---|---|---|
| Revenues | ₹1,230 Cr | ₹1,114 Cr | ₹1,009 Cr | ₹1,356 Cr | ₹849 Cr |
| Expenses | ₹905 Cr | ₹847 Cr | ₹763 Cr | ₹1,042 Cr | ₹705 Cr |
| Operating Profit (Excl OI) | ₹325 Cr | ₹268 Cr | ₹246 Cr | ₹314 Cr | ₹144 Cr |
| Other Income | ₹18 Cr | ₹13 Cr | ₹18 Cr | ₹70 Cr | ₹28 Cr |
| Interest | ₹0.77 Cr | ₹0.42 Cr | ₹0.80 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Depreciation | ₹28 Cr | ₹27 Cr | ₹30 Cr | ₹29 Cr | ₹21 Cr |
| Profit Before Tax | ₹314 Cr | ₹253 Cr | ₹233 Cr | ₹355 Cr | ₹158 Cr |
| Profit After Tax | ₹229 Cr | ₹193 Cr | ₹177 Cr | ₹254 Cr | ₹102 Cr |
| Consolidated Net Profit | ₹229 Cr | ₹193 Cr | ₹177 Cr | ₹254 Cr | ₹839 Cr |
| Earnings Per Share (Rs) | ₹138.23 | ₹115.98 | ₹106.51 | ₹153.06 | ₹61.29 |
| PAT Margin (%) | 17.28 | 16.35 | 17.53 | 18.74 | 11.98 |
| ROE(%) | 33.94 | 29.41 | 22.04 | 20.79 | 8.95 |
| ROCE(%) | 46.07 | 38.45 | 29.08 | 29.01 | 13.90 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 7,790.0 Cr |
| Revenue (TTM) | : | ₹ 1,237.0 Cr |
| Net Profit(TTM) | : | ₹ 226.7 Cr |
| EPS (TTM) | : | ₹ 136.5 |
| P/E (TTM) | : | 34.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PROCTER & GAMBLE HEALTH | -1.7% | -6% | 1.3% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
PROCTER & GAMBLE HEALTH Revenues
[BOM: 500126|NSE : PGHL]
| Y-o-Y | 10.34 % |
| 5 Yr CAGR | 9.70 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Jun2023 | ₹1,230 Cr | 10.34 | |
| Jun2022 | ₹1,114 Cr | 10.48 | |
| Jun2021 | ₹1,009 Cr | -25.60 | |
| Jun2020 | ₹1,356 Cr | 59.70 | |
| Dec2018 | ₹849 Cr | - | |
PROCTER & GAMBLE HEALTH Operating Profit
[BOM: 500126|NSE : PGHL]
| Y-o-Y | 21.29 % |
| 5 Yr CAGR | 22.51 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Jun2023 | ₹325 Cr | 21.29 | |
| Jun2022 | ₹268 Cr | 8.80 | |
| Jun2021 | ₹246 Cr | -21.73 | |
| Jun2020 | ₹314 Cr | 118.08 | |
| Dec2018 | ₹144 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 9.91 % |
| 5 Yr CAGR | 11.66 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2023 | 26.4% | 9.91 | |
| Jun2022 | 24.02% | -1.52 | |
| Jun2021 | 24.39% | 5.22 | |
| Jun2020 | 23.18% | 36.51 | |
| Dec2018 | 16.98% | - | |
PROCTER & GAMBLE HEALTH Profit After Tax
[BOM: 500126|NSE : PGHL]
| Y-o-Y | 19.19 % |
| 5 Yr CAGR | -27.68 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2023 | ₹229 Cr | 19.19 | |
| Jun2022 | ₹193 Cr | 8.89 | |
| Jun2021 | ₹177 Cr | -30.42 | |
| Jun2020 | ₹254 Cr | -69.71 | |
| Dec2018 | ₹839 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 5.69 % |
| 5 Yr CAGR | 9.59 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2023 | 17.28 % | 5.69 | |
| Jun2022 | 16.35 % | -6.73 | |
| Jun2021 | 17.53 % | -6.46 | |
| Jun2020 | 18.74 % | 56.43 | |
| Dec2018 | 11.98 % | - | |
PROCTER & GAMBLE HEALTH Earnings Per Share (EPS)
[BOM: 500126|NSE : PGHL]
| Y-o-Y | 19.18 % |
| 5 Yr CAGR | 22.55 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Jun2023 | ₹138 | 19.18 | |
| Jun2022 | ₹116 | 8.89 | |
| Jun2021 | ₹107 | -30.41 | |
| Jun2020 | ₹153 | 149.73 | |
| Dec2018 | ₹61 | - | |
PROCTER & GAMBLE HEALTH Return on Capital Employed (ROCE)
[BOM: 500126|NSE : PGHL]
| Y-o-Y | 19.82 % |
| 5 Yr CAGR | 34.93 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Jun2023 | 46.07% | 19.82 | |
| Jun2022 | 38.45% | 32.22 | |
| Jun2021 | 29.08% | 0.24 | |
| Jun2020 | 29.01% | 108.71 | |
| Dec2018 | 13.9% | - | |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
| Current Share Price | : | ₹4,692.8 |
| Current MarketCap | : | ₹ 7,790.0 Cr |
| Updated EOD on | : | Apr 18,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PROCTER & GAMBLE HEALTH | -1.7% |
-6% |
1.3% |
| SENSEX | -2.9% |
-0.4% |
20% |
PROCTER & GAMBLE HEALTH related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE 250 SMALLCAP | -0.9% | 12.1% | 61.4% |
| S&P BSE SMALL CAP | -1.1% | 11.8% | 62% |
| S&P BSE 400 MIDSMALLCAP | -1.2% | 8.6% | 57.2% |
| S&P BSE MIDSMALLCAP | -1.2% | 9.4% | 62.3% |
| S&P BSE ALLCAP | -2.2% | 3.9% | 37% |
No NSE index found
You may also like the below Video Courses
FAQ about PROCTER & GAMBLE HEALTH Financials
How the annual revenues of PROCTER & GAMBLE HEALTH have changed ?
The Revenues of PROCTER & GAMBLE HEALTH have increased by 10.34% YoY .
How the Earnings per Share (EPS) of PROCTER & GAMBLE HEALTH have changed?
The Earnings Per Share (EPS) of PROCTER & GAMBLE HEALTH has increased by 19.18 % YoY .
Check out Intrinsic Value of Peers of PROCTER & GAMBLE HEALTH
Compare Stock Analytics of Peers of PROCTER & GAMBLE HEALTH
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
